Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $125.5 million.

  • Praxis Precision Medicines' Change in Acquisitions & Divestments rose 10405.69% to $125.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.3 million, marking a year-over-year increase of 37940.49%. This contributed to the annual value of $123.0 million for FY2024, which is 21544.87% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Change in Acquisitions & Divestments of $125.5 million as of Q3 2025, which was up 10405.69% from $59.3 million recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Change in Acquisitions & Divestments high stood at $125.5 million for Q3 2025, and its period low was $3.0 million during Q2 2024.
  • Over the past 4 years, Praxis Precision Medicines' median Change in Acquisitions & Divestments value was $53.2 million (recorded in 2022), while the average stood at $49.4 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 8571.43% in 2023, then skyrocketed by 187656.67% in 2025.
  • Praxis Precision Medicines' Change in Acquisitions & Divestments (Quarter) stood at $22.6 million in 2022, then tumbled by 77.87% to $5.0 million in 2023, then soared by 1070.0% to $58.5 million in 2024, then soared by 114.61% to $125.5 million in 2025.
  • Its Change in Acquisitions & Divestments was $125.5 million in Q3 2025, compared to $59.3 million in Q2 2025 and $66.0 million in Q1 2025.